Khan, Safi U <br/><br/>
Association of Lowering Low-Density Lipoprotein Cholesterol With Contemporary Lipid-Lowering Therapies and Risk of Diabetes Mellitus: A Systematic Review and Meta-Analysis.  [electronic resource] 

 -  Journal of the American Heart Association  04 2019 
 - e011581 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Systematic Review 
<br/><br/><label>ISSN: </label>2047-9980 
<br/><br/><label>Standard No.: </label>10.1161/JAHA.118.011581  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Humanized--adverse effects<br/>Anticholesteremic Agents--adverse effects<br/>Cholesterol, LDL--drug effects<br/>Diabetes Mellitus--chemically induced<br/>Ezetimibe--adverse effects<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--adverse effects<br/>PCSK9 Inhibitors<br/>Randomized Controlled Trials as Topic<br/>Risk Factors